• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives N-alkylindoles

Professional Introduction to 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide (CAS No. 895998-48-8)

2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide, identified by its CAS number 895998-48-8, is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and drug discovery. This compound belongs to a class of molecules characterized by the presence of an indole core, a structural motif renowned for its biological activity and therapeutic potential. The structural framework of this molecule incorporates several key functional groups, including a methanesulfonyl substituent and a fluorophenyl moiety, which contribute to its unique chemical properties and biological interactions.

The indole ring system in 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide is particularly noteworthy, as indole derivatives have been extensively studied for their pharmacological effects. Indole-based compounds are known to exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of the 3-chlorophenyl group further modulates the electronic and steric properties of the molecule, influencing its binding affinity and selectivity towards biological targets.

The methanesulfonyl group, represented as -SO₂-CH₃, is another critical feature of this compound. This functional group is often employed in medicinal chemistry to enhance solubility, improve metabolic stability, and increase binding interactions with protein targets. The methanesulfonyl moiety can form strong hydrogen bonds with polar residues in proteins, making it a valuable tool for designing high-affinity ligands.

The fluorine atom in the 4-fluorophenyl group adds another layer of complexity to the molecule's behavior. Fluorine substitution is a common strategy in drug design due to its ability to modulate lipophilicity, metabolic stability, and electronic properties of aromatic rings. In particular, fluorine atoms can enhance binding affinity by participating in hydrophobic interactions and by influencing the conformational flexibility of the molecule.

In recent years, there has been growing interest in developing novel indole derivatives as potential therapeutic agents. Several studies have highlighted the promising applications of indole-based compounds in treating various diseases, including cancer, neurodegenerative disorders, and infectious diseases. The compound 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide has been investigated for its potential biological activities, particularly in the context of oncology research.

Cancer research has seen significant advancements with the development of targeted therapies that exploit specific molecular interactions. Indole derivatives have been shown to interfere with key signaling pathways involved in cancer cell proliferation and survival. For instance, some indole compounds have demonstrated inhibitory effects on enzymes such as tyrosine kinases and cyclin-dependent kinases (CDKs), which are crucial for cancer cell growth and division.

The structural features of 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide make it an attractive candidate for further investigation as a potential anticancer agent. The combination of the indole core, the methanesulfonyl group, and the fluorophenyl moiety suggests that this compound may exhibit multiple modes of action. It could interact with both intracellular signaling pathways and extracellular matrix components, potentially leading to synergistic therapeutic effects.

Moreover, computational studies have been instrumental in understanding the molecular interactions of this compound. Molecular docking simulations have revealed that 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide can bind to various protein targets with high affinity. These targets include enzymes involved in DNA replication and repair, as well as transcription factors that regulate gene expression.

The synthesis of this compound involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques have been employed to introduce the desired functional groups while maintaining regioselectivity. The use of palladium-catalyzed cross-coupling reactions has been particularly useful in constructing the indole core and incorporating the fluorine atom into the phenyl ring.

In conclusion, 2-{3-(3-chlorophenyl)methanesulfonyl-1H-indol-1-yl}-N-(4-fluorophenyl)acetamide (CAS No. 895998-48-8) is a structurally complex organic compound with significant potential in pharmaceutical research. Its unique combination of functional groups makes it an attractive candidate for further investigation as a therapeutic agent. Ongoing studies aim to elucidate its biological activities and develop novel drug candidates based on its structural framework.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)